Literature DB >> 25721761

In the strategies to prevent asthma exacerbations, allergic asthma needs specific treatment.

Cristoforo Incorvaia1, Erminia Ridolo.   

Abstract

No generally accepted definition of asthma exacerbation is thus far available, though in 2012 an expert committee endorsed by the National Institute of Health proposed such definition as "a worsening of asthma requiring the use of systemic corticosteroids to prevent a serious outcome". Graham and Eid reviewed the impact of asthma exacerbations, and noted that, analysing the outcomes with existing treatments, many patients with asthma remain symptomatic and experience exacerbations. This requires the introduction of new strategies to more effectively reduce the exacerbation risk, based on correct diagnosis, stopping smoking, correct inhaler technique, consistent adherence, weight management, and gaining control with the addition of medication". Indeed, as allergic asthma is the most common form, a specific approach by allergen immunotherapy should receive more attention. Actually, the efficacy of immunotherapy in allergic asthma, by the subcutaneous or the sublingual route, is supported by robust meta-analyses. The most important allergen source causing asthma is the house dust mite, but an increasing role for molds is apparent due to the ongoing climate change.

Entities:  

Keywords:  Allergen immunotherapy; Allergic asthma; Asthma exacerbation; GINA guidelines; Omalizumab

Mesh:

Substances:

Year:  2015        PMID: 25721761     DOI: 10.1185/03007995.2015.1024215

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  2 in total

1.  Omalizumab in middle-aged or older patients with severe allergic asthma-COPD overlap.

Authors:  Luisa Ricciardi; Francesco Papia; Marta Liotta; Francesca Cicero; Stefania Isola; Gennaro Tartarisco; Fabiana Furci; Sebastiano Gangemi
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

Review 2.  Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.

Authors:  Khalil Ansarin; Davood Attaran; Hamidreza Jamaati; Mohammad Reza Masjedi; Hamidreza Abtahi; Ali Alavi; Masoud Aliyali; Amir Mohammad Hashem Asnaashari; Reza Farid-Hosseini; Seyyed Mohammad Ali Ghayumi; Hassan Ghobadi; Atabak Ghotb; Abolhassan Halvani; Abbas Nemati; Mohammad Hossein Rahimi Rad; Masoud Rahimian; Ramin Sami; Hamid Sohrabpour; Sasan Tavana; Mohammad Torabi-Nami; Parviz Vahedi
Journal:  Tanaffos       Date:  2015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.